Home/Create Medicines/Jian Ding, PhD
JD

Jian Ding, PhD

Vice President, Translational Research

Create Medicines

Create Medicines Pipeline

DrugIndicationPhase
MT-304Breast CancerPhase 1
CRT-401Epithelial TumorsPreclinical
CRT-402B-cell DepletionPreclinical
MT-303Frontline Hepatocellular Carcinoma (HCC)Phase 2
MT-302Frontline Gastroesophageal Junction (GEJ) CancerPhase 2